Drug · DIN 02516756
RIZATRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 7, 2022; first marketed January 7, 2022.
- Drug Identification Number (DIN)
- 02516756
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2021: NOC 26047Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named RIZATRIPTAN
- DIN 02409399 · Approved
- DIN 02409402 · Approved
- DIN 02516721 · Approved